APA (7th ed.) Citation

YC, C., ML, H., HL, L., SW, H., CF, C., HY, Y., . . . LM, C. (2025). Identification of PTGR2 inhibitors as a new therapeutic strategy for diabetes and obesity. EMBO molecular medicine, 17(5), 938. https://doi.org/10.1038/s44321-025-00216-4

Chicago Style (17th ed.) Citation

YC, Chang, et al. "Identification of PTGR2 Inhibitors as a New Therapeutic Strategy for Diabetes and Obesity." EMBO Molecular Medicine 17, no. 5 (2025): 938. https://doi.org/10.1038/s44321-025-00216-4.

MLA (9th ed.) Citation

YC, Chang, et al. "Identification of PTGR2 Inhibitors as a New Therapeutic Strategy for Diabetes and Obesity." EMBO Molecular Medicine, vol. 17, no. 5, 2025, p. 938, https://doi.org/10.1038/s44321-025-00216-4.